DiscGenics
Latest round
- Series C
Last raised
- Aug 2020
Total raised
- $64M
Investors
- 5
About DiscGenics
DiscGenics, Inc.Founded in 2007 and headquartered in Salt Lake City, US, DiscGenics, Inc. specializes in innovative therapies for spinal health.DiscGenics specializes in developing innovative regenerative therapies aimed at addressing chronic back pain, particularly through their core product, IDCT (rebonuputemcel). This investigational product is an allogeneic, injectable cell therapy that uses proprietary Discogenic Cells to target mild to moderate adult lumbar disc degeneration. By focusing on the unique environment of degenerated spinal discs, DiscGenics aims to alleviate pain and restore functionality for patients suffering from degenerative diseases of the spine. The primary end users of IDCT are adults experiencing chronic back pain due to disc degeneration, with a focus on enhancing their quality of life.DiscGenics operates within a healthcare framework that is centered on innovative therapies and clinical research. The company’s transaction model involves direct collaborations with hospitals and clinics, allowing for the administration of their cell therapy to patients enrolled in clinical studies. As the product advances through regulatory pathways, potential revenue streams may include agreements with healthcare providers for the integration of IDCT into treatment protocols, contingent upon successful clinical outcomes and subsequent approvals. The company aims to expand its clinical trials and increase outreach to healthcare providers.
Who invested in DiscGenics
5 investors across 2 rounds
See all investors in DiscGenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DiscGenics
Who invested in DiscGenics?
DiscGenics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DiscGenics raised?
DiscGenics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DiscGenics last raise money?
DiscGenics's most recent round on record is a Series C, in Aug 2020.
What does DiscGenics do?
DiscGenics is a biotechnology company.
Where is DiscGenics headquartered?
DiscGenics is headquartered in Salt Lake City, US.
Which VCs invest in companies like DiscGenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DiscGenics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like DiscGenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.